文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

残障青少年女孩的人乳头瘤病毒疫苗接种覆盖率及决定因素:范围综述

HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review.
PubMed 文献 · Vaccine · 2025-11-11

该范围综述遵循乔安娜布里格斯研究所指南,检索四个数据库,纳入24项研究,考察低收入、中等收入和高收入国家残障青少年女孩的人乳头瘤病毒(HPV)疫苗接种覆盖率及促进与阻碍因素,并描述研究方法。研究报告的HPV疫苗接种覆盖率范围为22.9%至87.4%;在设有对照队列的11项研究中,有6项报告残障青少年女孩的HPV疫苗接种覆盖率低于无残障者;个体与人际层面的促进和阻碍因素报告频率高于组织、环境和政策层面。

要点

  • 纳入24项研究,报告残障青少年女孩HPV疫苗接种覆盖率范围为22.9%至87.4%。
  • 设有对照队列的11项研究中,6项报告残障青少年女孩HPV疫苗接种覆盖率低于无残障者。
  • 个体与人际层面的促进和阻碍因素报告频率高于组织、环境和政策层面。

核心结论

  • 当前文献显示残障青少年女孩的HPV疫苗接种覆盖率存在差异,并识别出多种促进和阻碍因素,研究方法多样。
  • 需要努力纳入理论框架指导研究,将研究扩展到低资源国家,并实施人群水平登记数据集。

研究设计与样本

  • 采用范围综述设计,遵循乔安娜布里格斯研究所指南,检索四个数据库的英文同行评审文献,纳入24项研究。
  • 检索范围覆盖低收入、中等收入和高收入国家中考察残障青少年女孩HPV疫苗接种的研究,对时间线和背景无限制。

主要发现

  • 研究报告的HPV疫苗接种覆盖率范围为22.9%至87.4%,采用多种研究方法得出这些估计值。
  • 设有对照队列的11项研究中,6项报告残障青少年女孩的HPV疫苗接种覆盖率低于无残障者。
  • 纳入研究报告的个体与人际层面促进和阻碍因素频率高于组织、环境和政策层面决定因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Human papillomavirus (HPV) vaccination has been scaled up in many countries in response to global calls for cervical cancer elimination. Adolescent females with disability face significant inequities when accessing healthcare and may be overlooked in vaccination programs and campaigns. We undertook a scoping review to examine HPV vaccination coverage and key enablers and barriers for this population. Our secondary aim was to describe the methodologies used to study this population to guide future research. METHODS: A scoping review was conducted using the Joanna Briggs Institute guidelines. Four databases were searched for English-language peer-reviewed literature examining HPV vaccination amongst adolescent girls with disability in low-, middle- and high-income countries, with no restrictions on timeline or context. HPV vaccination coverage rates and study methodologies were extracted into tables, and key enablers and barriers were mapped to the socio-ecological framework. RESULTS: Twenty-four studies were included. Studies reported a wide range in HPV vaccination coverage from 22.9 % to 87.4 % and a variety of research methods were used to derive these estimates. Slightly more than half of studies (n = 6/11) which included a comparison cohort reported lower HPV vaccination coverage rates in adolescent females with disability compared to those without disability. Included studies found individual and interpersonal level enablers and barriers at a greater frequency compared to organisational, environmental and policy level determinants. CONCLUSION: The current literature shows disparities in HPV vaccination coverage and identifies a diverse range of enablers and barriers for adolescent girls with disability, using multiple research methodologies. Efforts are needed to incorporate theoretical frameworks to guide research, extend research to low-resource countries and implement population level registry data sets.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kumar P, Bateson D, Costa T, et al. HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review. Vaccine. 2025. PMID: 41223768. doi:10.1016/j.vaccine.2025.127968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。